Inventor
Gerald Kleymann
Inventor
Bad Salzuflen, DE
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes23%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
11,078,168Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase202110,590,094Aminothiazole derivatives useful as antiviral agents202010,301,272Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[g]201910,150,762Trifluoromethyl alcohols as modulators of RORgt201810,080,744Thiazoles as modulators of RORgt20189,861,618'Thiazoles as modulators of RORγt'20189,850,236Trifluoromethyl alcohols as modulators of RORgt20179,845,319Amide substituted thiazoles as modulators of RORyt20179,815,851'Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases'20179,458,104'Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ'20168,946,446'Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases'20158,940,722'Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease'20157,960,387'2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses'20117,883,713'Topical application of thiazolyl amides'20117,105,553'Thiazolyl amide derivatives'20066,500,817'Thiazolyl urea derivatives and their utilization as antiviral agents'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2006Patents assigned to BAYER AG (2)· patent assignee history
2002Based in Wuppertal, DE· patent location history
2006–2021Based in Bad Salzuflen, DE· patent location history
2015–2019Patents assigned to PHENEX PHARMACEUTICALS AG (5)· patent assignee history
2015Patents assigned to HOFFMANN THOMAS (2)· patent assignee history
2015Patents assigned to KINZEL OLAF (2)· patent assignee history
2017–2018Patents assigned to JANSSEN PHARMACEUTICA NV (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 5 | 2017–2018 |
| PHENEX PHARMACEUTICALS AG | 5 | 2015–2019 |
| BAYER AG | 2 | 2002–2006 |
| HOFFMANN THOMAS | 2 | 2015 |
| KINZEL OLAF | 2 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bad Salzuflen, DE | 15 | 2006–2021 |
| Wuppertal, DE | 1 | 2002 |